Compare GLOO & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GLOO | ANGO |
|---|---|---|
| Founded | 2013 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 423.7M | 462.0M |
| IPO Year | N/A | 2004 |
| Metric | GLOO | ANGO |
|---|---|---|
| Price | $5.81 | $10.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $13.75 | ★ $19.33 |
| AVG Volume (30 Days) | 52.5K | ★ 315.9K |
| Earning Date | 01-01-0001 | 04-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.92 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $291,010,000.00 |
| Revenue This Year | $295.35 | $9.11 |
| Revenue Next Year | $97.83 | $4.94 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $4.80 | $8.27 |
| 52 Week High | $9.91 | $13.99 |
| Indicator | GLOO | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 49.18 | 43.73 |
| Support Level | $5.05 | $10.37 |
| Resistance Level | $5.95 | $11.03 |
| Average True Range (ATR) | 0.59 | 0.33 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 38.61 | 28.46 |
Gloo Holdings Inc is engaged in building a technology platform company. It has provided a breadth of products, services, and solutions to the two primary stakeholders at the core of the faith and flourishing ecosystem: (1) network capability providers (NCPs) and (2) the churches and frontline organizations (CFLs) it serves. The company serves as a digital infrastructure between NCPs and CFLs. By facilitating efficient exchange between the two, Gloo enables both sides to succeed; CFLs gain access to resources and NCPs benefit from efficient distribution and targeted reach. This creates a virtuous cycle, strengthening the platform with each interaction. The Gloo platform includes a suite of technology, marketplace, and service solutions offered directly from Gloo or from Gloo's subsidiaries.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.